Health News (Reuters)

White House says rollback of Obamacare must be part of short-term fix

WASHINGTON (Reuters) - A senior White House aide said on Thursday that U.S. President Donald Trump would demand steps toward repealing Obamacare in any healthcare legislation, comments that cast doubt on the prospects for a short-term bill to shore up insurance markets.

Celgene abandons Crohn's drug trials, shares drop

(Reuters) - Celgene Corp said it would abandon testing a drug to treat Crohn's disease, in a major setback to the U.S. biotechnology company's pipeline amid attempts to lower dependence on its mainstay Revilimid.

More Republican senators back bipartisan Obamacare deal

WASHINGTON (Reuters) - A bipartisan deal to stabilize Obamacare by restoring billions of dollars of federal subsidies to health insurers picked up Republican support in the Senate on Thursday despite President Donald Trump's opposition, but still faced an uphill battle.

Beauty standards may be broadening

(Reuters Health) - Americans have grown to appreciate beauty across more skin types and ages during the past three decades, if People magazine is any indication, a new study suggests.

Celgene to stop testing Crohn's drug, shares drop

(Reuters) - Celgene Corp said it would abandon testing a drug to treat Crohn's disease, an inflammatory bowel disease, following a risk-benefit analysis by a data monitoring committee, in a major setback to the drugmaker's pipeline.

Paleo diet may contribute to iodine deficiency

(Reuters Health) - Older women on a so-called Paleolithic diet – which tries to mimic the diet of cavemen living in the stone age - may be more likely to develop iodine deficiency than their counterparts who don’t eat this way, a small Swedish experiment suggests.

Merck cyber attack may cost insurers $275 million: Verisk's PCS

NEW YORK (Reuters) - Insurers could pay $275 million to cover the insured portion of drugmaker Merck & Co's loss from a cyber attack in June, according to a forecast by Verisk Analytics Inc's Property Claim Services (PCS) unit.

New H7N9 bird flu strain in China has pandemic potential: study

CHICAGO (Reuters) - Lab experiments on a new strain of the H7N9 bird flu circulating in China suggest the virus can transmit easily among animals and can cause lethal disease, raising alarms that the virus has the potential for triggering a global human pandemic, researchers reported on Thursday.

Ukraine passes long-delayed health reforms praised by West

KIEV (Reuters) - Ukrainian lawmakers voted through a long-delayed overhaul of the health system on Thursday that the state's Western backers say will raise standards and tackle a culture of bribe-taking in surgeries and hospitals.

FDA approves Gilead cancer gene therapy; price set at $373,000

(Reuters) - U.S. regulators approved on Wednesday a new therapy for a type of lymphoma, which was developed by Gilead Science Inc's Kite Pharma, marking the second approval for this potentially revolutionary approach to fighting cancer.

Novartis to shut U.S. generics plant, cut 450 jobs

ZURICH (Reuters) - Swiss drugmaker Novartis is to cut 450 jobs in the United States over the next two years as it gradually shuts a generics manufacturing plant in Colorado and discontinues some products in the face of intense price pressures.

China biotech's 'coming out party' masks long road ahead

LONDON/SHANGHAI (Reuters) - Investors are betting on China's potential to feed the global pharmaceutical pipeline, putting a multi-billion-dollar price tag on a handful of stocks, even as the country struggles to close a huge R&D gap with the West.

Pages